BIOSYENT INC (RX.CA) Stock Cash Flow
TSX-V:RX - TSX Venture Exchange - CA0906901081 - Common Stock - Currency: CAD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 7.27M | 6.46M | 5.46M | 6.28M | 3.80M | |||
| Depreciation Amortization | 590.00K | 455.30K | 451.00K | 457.10K | 510.40K | |||
| Income Taxes - Deferred | -129.20K | -134.00K | -8.80K | -68.30K | -27.60K | |||
| Change In Working Capital | 888.40K | -1.45M | -1.09M | -2.18M | 2.49M | |||
| Interest Paid | 59.20K | N/A | N/A | N/A | N/A | |||
| Taxes Paid | 2.36M | 2.41M | 1.76M | 2.32M | N/A | |||
| Other non cash items | 44.20K | -275.60K | 140.80K | 179.60K | 122.30K | |||
| OPERATING CASH FLOW | 8.66M | 5.05M | 4.95M | 4.67M | 6.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -42.30K | -59.50K | -46.80K | -84.70K | -13.60K | |||
| Other Investing Activity | 3.33M | 943.40K | -10.74M | -4.75M | 3.40M | |||
| INVESTING CASH FLOW | 3.29M | 883.90K | -10.79M | -4.84M | 3.39M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -183.30K | -242.50K | -239.00K | -237.20K | -237.20K | |||
| Stock Issued/Repurchased | -4.93M | -3.19M | -3.65M | -1.84M | -3.13M | |||
| Dividend Paid | -2.08M | -1.91M | -484.00K | N/A | N/A | |||
| Other Financing Activity | -639.30K | -443.50K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -7.83M | -5.78M | -4.37M | -2.08M | -3.37M | |||
| Exchange Rate Effect | 5.90K | -34.30K | 42.10K | -18.60K | -61.40K | |||
| CHANGE IN CASH | 4.13M | 120.00K | -10.17M | -2.26M | 6.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 8.66M | 5.05M | 4.95M | 4.67M | 6.89M | |||
| Capital Expenditure | -42.30K | -59.50K | -46.80K | -84.70K | -13.60K | |||
| FREE CASH FLOW | 8.62M | 5.00M | 4.90M | 4.59M | 6.88M | |||
All data in CAD